Multi-institutional study of allogeneic bone marrow transplantation using myeloablative busulfan (Bu)/fludarabine (Flu) conditioning and short-course, single-agent graft-versus-host disease (GVHD) prophylaxis with high-dose, post-transplantation cyclophosphamide (PTCy).
Christopher George Kanakry
No relevant relationships to disclose
Paul V. O'Donnell
Research Funding - Otsuka
Marcos J.G. De Lima
No relevant relationships to disclose
Wei Wei
No relevant relationships to disclose
Terry Furlong
No relevant relationships to disclose
Marta Medeot
No relevant relationships to disclose
Richard J. Jones
No relevant relationships to disclose
Peter F. Thall
No relevant relationships to disclose
Borje Andersson
Research Funding - Otsuka
Leo Luznik
Research Funding - Otsuka